Pro Share Advisors LLC Cytek Biosciences, Inc. Transaction History
Pro Share Advisors LLC
- $42.5 Billion
- Q4 2024
A detailed history of Pro Share Advisors LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 36,241 shares of CTKB stock, worth $174,319. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,241
Previous 25,028
44.8%
Holding current value
$174,319
Previous $138,000
70.29%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CTKB
# of Institutions
150Shares Held
74MCall Options Held
1KPut Options Held
0-
Black Rock Inc. New York, NY17.1MShares$82.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$56.4 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD8.25MShares$39.7 Million1.27% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$32 Million1.65% of portfolio
-
State Street Corp Boston, MA4.51MShares$21.7 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $648M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...